The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases

Hüseyin Vural; Ferah Armutçu; Ömer Akyol; Ralf Weiskirchen

doi:10.1016/j.cca.2021.10.018

RDLNetworkEkosistem

Hakkımızda SSS

Giriş yap Başla

Hakkımızda SSS Gizlilik Şartlar İletişim

The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases — Hüseyin Vural (2021) | RDL Network

Back

Home
Publications
The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases

Shared by

Ralf Weiskirchen

The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases

Article 2021 en

Authors

HV
Hüseyin Vural
FA
Ferah Armutçu
ÖA
Ömer Akyol

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1016/j.cca.2021.10.018
Year: 2021
Published: —
Language: en

Article Details

Volume: 523
Link Of The Paper: https://doi.org/10.1016/j.cca.2021.10.018

Timeline

Created:June 19, 2026

Related publications

Article2018

Parental non‐alcoholic fatty liver disease increases risk of non‐alcoholic fatty liver disease in offspring

Michelle T. Long, Ellen B. Gurary, Joseph M. Massaro, Jiantao Ma, Udo Hoffmann, Raymond T. Chung, Emelia Benjamin, Rohit Loomba

Article2018

Su1513 - The Association of Non-Alcoholic Fatty Liver Disease and Altered Cardiac Structure and Function

Laura Chiu, Alison Pedley, Joseph M. Massaro, Gary F. Mitchell, Ramachandran S. Vasan, Emelia Benjamin, Susan Cheng, Michelle T. Long

Article2021

Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism

Songsong Wang, Feiya Sheng, Liang Zou, Jianbo Xiao, Peng Li

Article2021

Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention

Frank Tacke, Ralf Weiskirchen

Article2023

The Pivotal Role of the Membrane-Bound O-Acyltransferase Domain Containing 7 in Non-Alcoholic Fatty Liver Disease

Preethi Chandrasekaran, Ralf Weiskirchen